Document Detail


Sclerotherapy in an undetected pregnancy - a catastrophe?
MedLine Citation:
PMID:  22825857     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
According to the guidelines and the manufacturer's information, pregnancy is a contraindication for sclerotherapy with Polidocanol. However, in some cases sclerotherapy has been conducted in a period when the pregnancy is not known by the patient. When pregnancy is diagnosed, patients and gynecologists often ask the phlebologist if there is an indication for the interruption of pregnancy. Up to now, there is only rare information on sclerotherapy, polidocanol and pregnancy. Current knowledge is summed up in this article together with case reports. The existing case reports and mainly retrospective case series on intended or accidentally conducted sclerotherapy with common sclerosants and doses show no increased risk for the mother and the unborn child. However, in view of the limited literature data available and the high probability for spontaneous regression of varicose veins postpartum, sclerotherapy should be avoided in pregnancy, if possible. Conservative measures during pregnancy or an elimination of varicose veins before pregnancy should be preferred. In single cases e.g. painful genitoanal varices, the use of sclerotherapy can be helpful even during pregnancy. Thereby, a very thorough clarification of the mother with a final written consent and an implementation according to the guidelines are especially important. According to the current data, there is no reason for an interruption after a sclerotherapy that has been conducted during undetected pregnancy.
Authors:
S Reich-Schupke; A Leiste; R Moritz; P Altmeyer; M Stücker
Related Documents :
3077737 - Current topics in artificial insemination of sheep.
18484297 - Kinetics of semicarbazide and nitrofurazone in chicken eggs and egg powders.
22305917 - A randomized controlled trial of different buccal misoprostol doses in mifepristone med...
7194367 - Sterility in mutant (tlx/tly) male mice. iii. in vitro fertilization.
3077737 - Current topics in artificial insemination of sheep.
12776887 - Biological correlates of extinction risk in bats.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  VASA. Zeitschrift für Gefässkrankheiten     Volume:  41     ISSN:  0301-1526     ISO Abbreviation:  VASA     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-07-24     Completed Date:  2012-09-06     Revised Date:  2012-10-19    
Medline Journal Info:
Nlm Unique ID:  0317051     Medline TA:  Vasa     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  243-7     Citation Subset:  IM    
Affiliation:
Vein Centre of the Departments of Dermatology & Vascular Surgery, Ruhr-University Bochum, Germany. s.reich-schupke@klinikum-bochum.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Female
Humans
Live Birth
Polyethylene Glycols / adverse effects*
Pregnancy
Pregnancy Tests
Pregnancy Trimester, First*
Risk Assessment
Risk Factors
Sclerosing Solutions / adverse effects*
Sclerotherapy / adverse effects*
Telangiectasis / therapy*
Treatment Outcome
Varicose Veins / therapy*
Chemical
Reg. No./Substance:
0/Polyethylene Glycols; 0/Sclerosing Solutions; 9002-92-0/polidocanol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quorum sensing: how bacteria can coordinate activity and synchronize their response to external sign...
Next Document:  Drug-eluting stents and drug-coated balloons in peripheral artery disease.